Repopulating glioma cell lines
http://www.100md.com
《细胞学杂志》
Kondo/NAS
Cancer therapies target rapidly dividing cells, which is a problem if tumors contain slow-growing undifferentiated cells that act as stem cell for the malignancy, as accumulating evidence suggests. Now, Toru Kondo, Takao Setoguchi, and Tetsuya Taga (Kumamoto University, Japan, and University of Cambridge, Cambridge, UK) show that this problem may be widespread. They find that several cancer cell lines maintain a small proportion of self-renewing cells.
To search for these potentially dangerous cells, Kondo's team tested several cancer cell lines for the presence of side populations (SP) of cells containing the breast cancer–resistant protein 1 (BCRP1), an ATP-dependent transporter found in many stem cells. Of six lines tested, four had BCRP1-containing SP cells that accounted for between 0.4% and 2.1% of the total population.
The growth of SP cells requires basic fibroblast growth factor (bFGF) and platelet-derived growth factor (PDGF). "bFGF seems to be essential for the self-renewal of C6 stem cell but is not enough to induce stem cell proliferation" says Kondo. In the presence of both growth factors, the SP cells proliferate but maintain their stem cell–like qualities.
When the authors isolated SP cells and allowed them to repopulate a culture, they found that the cells produce both SP and non-SP cells. By contrast, non-SP cells cannot be induced to take on SP traits, suggesting that the SP cells are the population's stem cells.
It is these SP cells that seem to be responsible for malignancy. SP cells injected into immunologically compromised mice generate aggressive, invasive cancers, whereas non-SP cells generally give rise only to local tumors. Since both cell types contain the same oncogenic mutations, the difference is probably due to epigenetic differences such as silencing, says Kondo. He and others are already looking for possible stem cell behavior switches, such as Bmi-1, an epigenetic factor recently shown to be concentrated in stem cells.
Reference:
Kondo, T., et al. 2004. Proc. Natl. Acad. Sci. USA. 10.1073/pnas.0307618100.(A small proportion of tumor cells have s)
婵烇絽娲犻崜婵囧閸涱喚顩烽柛娑卞墰鏉╂棃鏌涘▎蹇撯偓浠嬪焵椤掆偓閸犳稓妲愬┑鍥┾枖鐎广儱妫涢埀顒夊灦楠炲骞囬鍛簥婵炶揪绲惧ú鎴犵不閿濆拋鍤堝Δ锔筋儥閸炴挳鏌曢崱鏇犲妽閻㈩垰缍婇幊锟犲箛椤撶偟浠愰梺鍦瑰ú銈囨閳哄懎违闁稿本绋掗悗顔剧磼閺冨倸啸濠⒀勵殜瀵爼宕橀妸褎鍓戞繛瀛樼矊妤犲摜鏁锔藉婵＄偛澧界粙濠囨煛婢跺﹤鏆曟慨鐟邦樀閺佸秴鐣濋崘顭戜户闂佽鍠撻崝蹇涱敇缂佹ḿ鈻旈柣鎴烇供閸斿啴鏌￠崒姘煑缂佹顦遍埀顒冾潐缁繘锝為敃鍌氱哗閻犻缚娅ｇ粔鍨€掑顓犫槈闁靛洤娲ㄩ埀顒傤攰濞夋盯宕㈤妶鍥ㄥ鐟滅増甯楅～澶愭偣閸ワ妇涓茬紒杈ㄧ箘閹风娀鎮滈挊澶夌病婵炲濮鹃崺鏍垂閵娾晜鍋ㄥù锝呭暟濡牓姊洪锝嗙殤闁绘搫绻濋獮瀣箣濠婂嫮鎷ㄩ梺鎸庣☉閺堫剟宕瑰⿰鍕浄妞ゆ帊鐒﹂弳顏堟煕閹哄秴宓嗛柍褜鍓氬銊╂偂閿熺姴瑙﹂幖鎼灣缁€澶娒归崗鍏肩殤闁绘繃鐩畷锟犲礃閼碱剚顔戦梺璇″枔閸斿骸鈻撻幋鐐村婵犲﹤鍟幆鍌毭归悩鎻掝劉婵犫偓閹殿喚纾鹃柟瀵稿Х瑜版煡鏌涢幒鏂库枅婵炲懎閰ｆ俊鎾晸閿燂拷Cancer therapies target rapidly dividing cells, which is a problem if tumors contain slow-growing undifferentiated cells that act as stem cell for the malignancy, as accumulating evidence suggests. Now, Toru Kondo, Takao Setoguchi, and Tetsuya Taga (Kumamoto University, Japan, and University of Cambridge, Cambridge, UK) show that this problem may be widespread. They find that several cancer cell lines maintain a small proportion of self-renewing cells.
To search for these potentially dangerous cells, Kondo's team tested several cancer cell lines for the presence of side populations (SP) of cells containing the breast cancer–resistant protein 1 (BCRP1), an ATP-dependent transporter found in many stem cells. Of six lines tested, four had BCRP1-containing SP cells that accounted for between 0.4% and 2.1% of the total population.
The growth of SP cells requires basic fibroblast growth factor (bFGF) and platelet-derived growth factor (PDGF). "bFGF seems to be essential for the self-renewal of C6 stem cell but is not enough to induce stem cell proliferation" says Kondo. In the presence of both growth factors, the SP cells proliferate but maintain their stem cell–like qualities.
When the authors isolated SP cells and allowed them to repopulate a culture, they found that the cells produce both SP and non-SP cells. By contrast, non-SP cells cannot be induced to take on SP traits, suggesting that the SP cells are the population's stem cells.
It is these SP cells that seem to be responsible for malignancy. SP cells injected into immunologically compromised mice generate aggressive, invasive cancers, whereas non-SP cells generally give rise only to local tumors. Since both cell types contain the same oncogenic mutations, the difference is probably due to epigenetic differences such as silencing, says Kondo. He and others are already looking for possible stem cell behavior switches, such as Bmi-1, an epigenetic factor recently shown to be concentrated in stem cells.
Reference:
Kondo, T., et al. 2004. Proc. Natl. Acad. Sci. USA. 10.1073/pnas.0307618100.(A small proportion of tumor cells have s)
|
閻庣敻鍋婇崰鏇熺┍婵犲洤妫橀柛銉㈡櫇瑜帮拷
闂佺ǹ绻楀▍鏇㈠极閻愮儤鍎岄柣鎰靛墮椤庯拷
闁荤姴娲ょ€氼垶顢欓幋锕€绀勯柣妯诲絻缂嶏拷
闂佺懓鍚嬬划搴ㄥ磼閵娾晛鍗抽柡澶嬪焾濡拷
闂佽浜介崝宀勬偤閵娧呯＜婵炲棙鍔栫粻娆撴煕濞嗘瑦瀚�
闂佸憡姊绘慨鎾矗閸℃稑缁╅柟顖滃椤ワ拷
|